New Key Statistics Module, Z-Score and F-Score
NAS:KYMR Key Ratios
| Market Cap $ M | 2,472.09 |
| Enterprise Value $ M | 2,010.35 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 2.77 |
| Price/Sales | 28.00 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 87.00 |
| EPS (TTM) $ | -2.34 |
| Beneish M-Score | -1.93 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -19.50 |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -12.02 |
| EV-to-EBITDA | -12.49 |
| PEG | -- |
| Shares Outstanding M | 64.77 |
| Net Margin (%) | -191.26 |
| Operating Margin % | -223.00 |
| Pre-tax Margin (%) | -191.26 |
| Quick Ratio | 8.55 |
| Current Ratio | 8.55 |
| ROA % (ttm) | -21.71 |
| ROE % (ttm) | -27.19 |
| ROIC % (ttm) | -60.26 |
| Dividend Yield % | -- |
| Altman Z-Score | 9.66 |
KYMR Number of Guru Trades
KYMR Volume of Guru Trades
Gurus Latest Trades with NAS:KYMR
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:KYMR is held by these investors
Total 2
Kymera Therapeutics Inc Insider Transactions
No Available Data
News about NAS:KYMR
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers